The discovery of cisplatin (cis-Pt (NH 3) 2 Cl 2) as an antineoplastic agent has focussed
attention on the rational design of metal complexes that can be potentially used in cancer …

Since the antitumor activity of cisplatin was discovered in 1967 by Rosenberg, platinum-
based anticancer drugs have played an important role in chemotherapy in clinic …

Platinum iodido complexes have long been recognized as synthetic intermediates of various
platinum complexes (eg, chlorido or carboxylato), including the world-wide used platinum …

The search for new scaffolds of medicinal significance combined with molecular shape
enhances their innovative potential and continues to attract the attention of researchers …

Three new ruthenium (II)–arene complexes, namely [(η 6-p-cymene) Ru (Me 2 dppz) Cl] PF
6 (1),[(η 6-benzene) Ru (Me 2 dppz) Cl] PF 6 (2) and [(η 6-p-cymene) Ru (aip) Cl] PF 6 …

The monocationic chloro complexes containing chelating N∩ N ligands:[(η 6-p-cymene) Ru
(L1–4) Cl]+(1–4), where L1= 4-methyl-1, 10-phenantroline, L2= dipyrido [3, 2-a: 2′, 3′-c] …

A series of platinum (II) diiodido complexes containing 7-azaindole derivatives, having the
general formula cis-[PtI2 (n aza) 2](1–8), has been prepared and thoroughly characterized …

Background: The discovery of cisplatin and the subsequent research revealed the
importance of dinitrogen-containing moiety for the anticancer action of metal complexes …

The interactions between alkynylplatinum (II) terpyridine complexes 1–3 and the G-
quadruplex DNA, including c-myc and telomeric quadruplex DNA, are investigated both in …

Abstract Complexes 1–4,[Ru (L)(bpy) 2] PF6, where bpy= 2, 2′-bipyridine; HL= 3-
methylpyridine-2-carboxylic acid (HL1), 6-methylpyridine-2-carboxylic acid (HL2), 5 …